Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia [Phase 3]
The Phase 3 CONNEX-3 trial evaluating Iclepertin for improving learning and memory in schizophrenia has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: C-Cog in Early Course Schizophrenia Study [Phase 4]
Phase 4 trial of C-Cog in early-course schizophrenia was terminated; results have been posted (2026-02-06).
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Study of SPG302 in Adults With Schizophrenia [Phase 2]
This is a Phase 2 clinical trial update for SPG302 in adults with schizophrenia; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia [Phase 3]
Open-label Phase 3 study assessing safety and tolerability of flexible-dose brexpiprazole as maintenance treatment in adolescents with schiz…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Illness Management and Recovery (IMR) in Danish Community Mental Health Centres [NA]
A completed clinical trial evaluating Illness Management and Recovery (IMR) in Danish community mental health centres, sponsored by Amager H…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients [NA]
Clinical trial update reports that transcranial random noise stimulation (tRNS) targeting the anterior cingulate cortex reduced cravings in …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder [Phase 1]
An open-label Phase 1 study evaluated the pharmacokinetics of three subcutaneous extended-release olanzapine formulations in adults with sch…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Effect of Psychoeducation -Based Motivational Interviewing on Knowledge and Hope in Schizophrenia [NA]
A completed clinical trial evaluating psychoeducation-based motivational interviewing to improve knowledge and hope in people with schizophr…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Berberine Improving Cognitive Impairments in Schizophrenia [NA]
Ongoing clinical trial in China evaluating whether berberine improves cognitive impairments associated with schizophrenia, sponsored by Tian…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia [Phase 2]
This Phase 2 trial investigated oxytocin's effects in schizophrenia using pharmaco-imaging to predict social functioning and clinical respon…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia [Phase 4]
Phase 4 study evaluating valbenazine for tardive dyskinesia in participants with schizophrenia, schizoaffective disorder, bipolar disorder, …
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women [Phase 1]
Phase 1 clinical trial evaluating potential interactions between SEP-380135 and other drugs in healthy adults, which has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia [Phase 1]
Open-label Phase 1 study comparing the bioavailability of TV-44749 to oral olanzapine in participants with schizophrenia; the trial status i…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Can Neural Network Instability in Schizophrenia be Improved With a Very Low Carbohydrate Ketogenic Diet? [NA]
A completed clinical trial (NCT05268809) examined whether a very low-carbohydrate ketogenic diet could improve neural network instability in…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Cinematic Virtual Reality Intervention for Improving Psychosocial Functioning in Individuals With Schizophrenia [NA]
This entry reports the completion of a clinical trial evaluating a cinematic virtual reality intervention to improve psychosocial functionin…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia [Phase 3]
Phase 3 study of TV-44749 in adults with schizophrenia completed, with results posted. The trial used a randomized, double-blind, placebo-co…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia [NA]
Status is COMPLETED for a trial evaluating virtual reality-based psychotherapy targeting negative symptoms in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder [Phase 4]
Phase 4 trial evaluating tachyphylaxis, tolerance, and withdrawal after treatment with intranasal dexmedetomidine (Igalmi) for agitation in …
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia [NA]
This clinical trial update notes the completion of a study evaluating social cognition in youth who have a first-degree relative with schizo…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia. [Phase 3]
Phase 3 trial results detailing the long-term safety and tolerability of an investigational drug in adults with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Mindfulness Psychoeducation for Schizophrenia [NA]
A clinical trial evaluating mindfulness-based psychoeducation for schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Multimodal MRI-guided rTMS to Treat Refractory Hallucinations [NA]
A completed clinical trial evaluated multimodal MRI-guided repetitive transcranial magnetic stimulation (rTMS) for treating refractory hallu…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness [NA]
This update reports the completion of a VA-sponsored clinical trial evaluating collaborative decision skills training for veterans with seri…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of ALTO-101 in Patients With Schizophrenia [Phase 2]
ALTO-101 is being studied in a Phase 2 trial for schizophrenia with cognitive impairment, and the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia [Phase 1]
A Phase 1 clinical trial evaluating the dose levels, safety, and drug levels after a single intramuscular injection of KarXT in participants…